Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: An automated tissue microarray study

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 1, 2009, Pages 12-17

  Huang, Wei ^a,b   Kanehira, Kazunori ^a,b   Drew, Sally ^b   Pier, Thomas ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Chromophobe renal cell carcinoma; CK7; Endogenenous avidin binding activity; Oncocytoma; RCCma; Vimentin

Indexed keywords

AVIDIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; TUMOR MARKER; VIMENTIN; MITOGEN ACTIVATED PROTEIN KINASE; RAGE PROTEIN, HUMAN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; AUTOMATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EOSINOPHILIA; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ANALYSIS; STAINING; TISSUE MICROARRAY; EVALUATION; METHODOLOGY; SENSITIVITY AND SPECIFICITY; STANDARD;

ADENOMA, OXYPHILIC; ANTIGENS, NEOPLASM; AUTOMATION; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 58749097480     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318173e79d     Document Type: Article

References (28)

1. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol. 1997;183:131-133.
2. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281-291. (Pubitemid 34184451)
3. Ljungberg B, Alamdari FI, Stenling R, et al. Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol. 1999;36:565-569. (Pubitemid 29516286)
4. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612-624. (Pubitemid 36514472)
5. Beck SD, Patel MI, Snyder ME, et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol. 2004;11:71-77.
6. Romis L, Cindolo L, Patard JJ, et al. Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. Eur Urol. 2004;45:53-57; discussion 57. (Pubitemid 37548994)
7. Gudbjartsson T, Hardarson S, Petursdottir V, et al. Renal oncocytoma: a clinicopathological analysis of 45 consecutive cases. BJU Int. 2005;96:1275-1279. (Pubitemid 41743923)
8. Amin MB, Crotty TB, Tickoo SK, et al. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol. 1997;21:1-12.
9. Perez-Ordonez B, Hamed G, Campbell S, et al. Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol. 1997; 21:871-883. (Pubitemid 27402806)
10. Skinnider BF, Jones EC. Renal oncocytoma and chromophobe renal cell carcinoma. A comparison of colloidal iron staining and electron microscopy. Am J Clin Pathol. 1999;111:796-803. (Pubitemid 29250110)
11. Bussolati G, Gugliotta P, Volante M, et al. Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopathology. 1997;31:400-407. (Pubitemid 27505355)
12. Vosse BA, Seelentag W, Bachmann A, et al. Background staining of visualization systems in immunohistochemistry: comparison of the Avidin-Biotin Complex system and the EnVision+ system. Appl Immunohistochem Mol Morphol. 2007;15:103-107. (Pubitemid 46673325)
13. Taki A, Nakatani Y, Misugi K, et al. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Mod Pathol. 1999;12:310-317. (Pubitemid 29133853)
14. Li G, Barthelemy A, Feng G, et al. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Histopathology. 2007;50:642-647. (Pubitemid 46495825)
15. Shomori K, Nagashima Y, Kuroda N, et al. ARPP protein is selectively expressed in renal oncocytoma, but rarely in renal cell carcinomas. Mod Pathol. 2007;20:199-207. (Pubitemid 46422174)
16. Zubakov D, Stupar Z, Kovacs G. Differential expression of a new isoform of DLG2 in renal oncocytoma. BMC Cancer. 2006;6:106. (Pubitemid 44150666)
17. Wu SL, Kothari P, Wheeler TM, et al. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod Pathol. 2002;15:712-717. (Pubitemid 34787306)
18. Garcia E, Li M. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Am J Clin Pathol. 2006;125:392-398. (Pubitemid 43327708)
19. Hornsby CD, Cohen C, Amin MB, et al. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Arch Pathol Lab Med. 2007;131:1541-1546. (Pubitemid 47606720)
20. Jiang Z, Wu CL, Woda BA, et al. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology. 2004;45:218-225. (Pubitemid 39294698)
21. Peyromaure M, Misrai V, Thiounn N, et al. Chromophobe renal cell carcinoma: analysis of 61 cases. Cancer. 2004;100:1406-1410. (Pubitemid 38366843)
22. Cote RJ, Cordon-Cardo C, Reuter VE, et al. Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex. Am J Pathol. 1990;136:1077-1084. (Pubitemid 20188494)
23. Markovic-Lipkovski J, Brasanac D, Todorovic V, et al. Immunomorphological characteristics of renal cell carcinoma. Histol Histopathol. 1995;10:651-659.
24. Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001;158: 1639-1651.
25. Avery AK, Beckstead J, Renshaw AA, et al. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24:203-210. (Pubitemid 30078709)
26. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol. 2005; 22:51-68. (Pubitemid 43163179)
27. Hes O, Brunelli M, Michal M, et al. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol. 2006;10:133-139. (Pubitemid 43765491)
28. Langner C, Ratschek M, Rehak P, et al. CD10 is a diagnostic and prognostic marker in renal malignancies. Histopathology. 2004;45: 460-467. (Pubitemid 39524320)